Neuren Pharmaceuticals Limited (ASX:NEU)
Share Pricing & News Healthcare

AUD 6.52

0.21 (3.328%)
(As on 2022-10-05 20:56:45 AEDT)
Previous Close Open Close*
6.31 6.35 6.52
Market Cap Dividend Yield (Annualized)
AUD 840.856M

Day Range
6.3L 6.61 H
52 WEEK HIGH LOW
1.625L 7.2 H

Chart Price & Information

Last Trade 6.52
Change% 3.3281
52 W H/L 7.200/1.625
EBITDA -10.569M
NPAT After Abnormal Items 0
Equity 0
ROE%
Total Liabilities 0
Total Revenue 0
Cash and Cash Equivalents 0

Stock Information

Share price 6.52
Market Cap 840.856M
Price/Gross Cash Flow
Dividend Yield Excluding Special
Ending Shares 0
52-Week Range 7.200-1.625
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized)
Earnings Yield 0.000
Net Tangible Asset (NTA)
P/E ratio 0.000
Sector P/E
EPS
EV/EBITDA
Net Profit Margin (%)
Gross Cash Flows Per Share
Net Gearing
Sales Per Share
Book Value Per Share

Similar Companies

Related Articles

About Company

NEUREN PHARMACEUTICALS LIMITED (ASX: NEU) is under the health care sector and is a biopharmaceutical company with a focus on neurological conditions. Developing drugs for neurological disorders is what the company is engaged into and trofinetide (NNZ-2566) and NNZ-2591 are some of its products. Hamilton Pharmaceuticals Inc. and Neuren Pharmaceuticals Inc. are its subsidiaries. The company’s incorporation year was 2001 and is in Burke Rd, Auckland, Australia.

Corporate Information


At the offices of Lowndes Jordan, Level 15, PWC Tower, 188 Quay Street, AUCKLAND, ., NEW ZEALAND, 1141

Phone:+61 3 9092 0480

Website:http://www.neurenpharma.com

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2023-08-23 2023
Report (Annual) 2023-04-26 2023
Report (Prelim) 2023-02-23 2023
Report (Quarterly) 2022-10-27 2022